Study reveals disparities in breastfeeding support based on disability
January 17th 2024A recent study using the Pregnancy Risk Assessment Monitoring System highlighted lower rates of breastfeeding initiation and duration among women with disabilities, emphasizing the need for targeted interventions to improve breastfeeding outcomes.
Low-dose vs high-dose calcium supplementation against preeclampsia
January 17th 2024A recent study revealed that low-dose calcium supplementation is noninferior to high-dose supplementation in preventing preeclampsia, shedding light on considerations for maternal health and pregnancy strategies worldwide.
The impact of physician awareness on decision-making preferences in urogynecology
January 16th 2024A recent study revealed that physician awareness of patients' desired level of decision-making significantly enhances satisfaction, highlighting the importance of tailored approaches for women with pelvic floor disorders seeking patient-centered care.
How cardiometabolic factors influence the link between education levels and pregnancy outcomes
January 15th 2024A recent study explored the impact of interventions for cardiometabolic factors in mitigating the influence of lower education levels on various adverse pregnancy outcomes, shedding light on mediators in maternal health.
Disparities in maternal health linked to severe maternal morbidity
January 11th 2024A recent study revealed that Black women, especially those facing extended travel distances for maternity care, are at a heightened risk of severe maternal morbidity, shedding light on needs for equitable maternal care policies in the United States.
Recent findings on low perinatal mortality in prenatally diagnosed vasa previa
January 8th 2024A comprehensive review reveals a minimal 0.5% risk of perinatal death in pregnancies diagnosed with vasa previa prenatally, emphasizing the importance of timely diagnosis and reduced stress for expectant families.
Long-term HPV vaccine efficacy: 10-year study reveals protection in youth
January 4th 2024A decade-long study confirms significant protection against human papillomavirus remains in patients vaccinated up to age 20, reinforcing the World Health Organization's single-dose vaccination recommendation for adolescents.